Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Controlled Trial of Laser Ablation Versus Surgery for the Treatment of Papillary Thyroid Microcarcinoma

NCT03377829 is registered in ClinicalTrials.gov with WeiWei Zhan as lead sponsor.

NCT NCT03377829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03377829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Controlled Trial of Laser Ablation Versus Surgery for the Treatment of Papillary Thyroid Microcarcinoma
Lead sponsor
WeiWei Zhan
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2017
Completion date
December 31, 2022
Enrollment
200 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer, treatment related cancer